Invitation to tender for the provision of Lymphoma Clonality Testing Reagents and Associated Controls for the Cancer Molecular Diagnostics Department within St James’s Hospital Dublin
TED · 728286-2026Contract noticeCloses in 29 days · 2026-11-19
Value
Estimated€375,000 · 375,000 EUR
Awarded—
Who already wins at this buyer
Firms with recorded awards from St James's Hospital in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| Chromsystems Instruments and Chemicals GmbH | 1 | €1,568,293 | 2026-07-16 |
| Clinisciences Limited | 1 | €764,481 | 2026-07-03 |
| Aquilant Medical ROI Ltd | 1 | €503,700 | 2026-08-04 |
Full buyer profile: what St James's Hospital buys and who wins it →
CPV codes
38000000 Laboratory, optical & precision equipment33696600 Medical equipment & pharmaceuticals33696500 Medical equipment & pharmaceuticalsDescription
The Cancer Molecular Diagnostics laboratory provides a range of molecular diagnostic tests for the diagnosis and management of haematological and solid malignancy. Currently this testing is divided among standard PCR, real-time PCR and Next Generation Sequencing (NGS) based diagnostics. While the laboratory is developing NGS based testing methodologies it is also seeking to secure access to reagents and consumables to continue to provide legacy clonality testing using capillary electrophoresis.